Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 378

1.

Proteomic profiling of cellular steatosis with concomitant oxidative stress in vitro.

Lockman KA, Htun V, Sinha R, Treskes P, Nelson LJ, Martin SF, Rogers SM, Le Bihan T, Hayes PC, Plevris JN.

Lipids Health Dis. 2016 Jul 2;15:114. doi: 10.1186/s12944-016-0283-7.

2.

Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.

Bird TG, Dimitropoulou P, Turner RM, Jenks SJ, Cusack P, Hey S, Blunsum A, Kelly S, Sturgeon C, Hayes PC, Bird SM.

PLoS One. 2016 Jun 16;11(6):e0156801. doi: 10.1371/journal.pone.0156801. eCollection 2016.

3.

Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.

Nelson LJ, Morgan K, Treskes P, Samuel K, Henderson CJ, LeBled C, Homer N, Grant MH, Hayes PC, Plevris JN.

Basic Clin Pharmacol Toxicol. 2016 Jun 10. doi: 10.1111/bcpt.12631. [Epub ahead of print]

PMID:
27285124
4.

Anticipated Regret and Organ Donor Registration: A Randomized Controlled Trial.

O'Carroll RE, Shepherd L, Hayes PC, Ferguson E.

Health Psychol. 2016 Jun 9. [Epub ahead of print]

PMID:
27280372
5.

Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs.

Weir A, McLeod A, Innes H, Valerio H, Aspinall EJ, Goldberg DJ, Barclay ST, Dillon JF, Fox R, Fraser A, Hayes PC, Kennedy N, Mills PR, Stanley AJ, Aitken C, Gunson R, Templeton K, Hunt A, McIntyre P, Hutchinson SJ.

Drug Alcohol Depend. 2016 Aug 1;165:53-60. doi: 10.1016/j.drugalcdep.2016.05.012. Epub 2016 May 28.

PMID:
27268294
6.

The use of hemostatic spray as an adjunct to conventional hemostatic measures in high-risk nonvariceal upper GI bleeding (with video).

Sinha R, Lockman KA, Church NI, Plevris JN, Hayes PC.

Gastrointest Endosc. 2016 Apr 21. pii: S0016-5107(16)30062-1. doi: 10.1016/j.gie.2016.04.016. [Epub ahead of print]

PMID:
27108061
7.

 Small bowel capsule endoscopy and portal hypertensive enteropathy in cirrhotic patients: results from a tertiary referral centre.

Dabos KJ, Yung DE, Bartzis L, Hayes PC, Plevris JN, Koulaouzidis A.

Ann Hepatol. 2016 May-Jun, 2016;15(3):394-401.

8.

Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis.

McAvoy NC, Semple S, Richards JM, Robson AJ, Patel D, Jardine AG, Leyland K, Cooper AS, Newby DE, Hayes PC.

Aliment Pharmacol Ther. 2016 May;43(9):947-54. doi: 10.1111/apt.13571. Epub 2016 Mar 7.

PMID:
26947424
9.

The changing face of liver transplantation for acute liver failure: Assessment of current status and implications for future practice.

Donnelly MC, Hayes PC, Simpson KJ.

Liver Transpl. 2016 Apr;22(4):527-35. doi: 10.1002/lt.24403.

PMID:
26823231
10.

Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis.

Kennedy OJ, Roderick P, Buchanan R, Fallowfield JA, Hayes PC, Parkes J.

Aliment Pharmacol Ther. 2016 Mar;43(5):562-74. doi: 10.1111/apt.13523. Epub 2016 Jan 25. Review.

PMID:
26806124
11.

The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohort.

Wang H, Innes H, Hutchinson SJ, Goldberg DJ, Allen S, Barclay ST, Bramley P, Fox R, Fraser A, Hayes PC, Kennedy N, Mills PR, Dillon JF.

Eur J Gastroenterol Hepatol. 2016 Apr;28(4):398-404. doi: 10.1097/MEG.0000000000000556.

PMID:
26695428
12.

Acetaminophen cytotoxicity is ameliorated in a human liver organotypic co-culture model.

Nelson LJ, Navarro M, Treskes P, Samuel K, Tura-Ceide O, Morley SD, Hayes PC, Plevris JN.

Sci Rep. 2015 Dec 3;5:17455. doi: 10.1038/srep17455.

13.

Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?

Yeung EN, Treskes P, Martin SF, Manning JR, Dunbar DR, Rogers SM, Le Bihan T, Lockman KA, Morley SD, Hayes PC, Nelson LJ, Plevris JN.

Lipids Health Dis. 2015 Aug 10;14:86. doi: 10.1186/s12944-015-0069-3.

14.

Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection.

Valerio H, Goldberg DJ, Lewsey J, Weir A, Allen S, Aspinall EJ, Barclay ST, Bramley P, Dillon JF, Fox R, Fraser A, Hayes PC, Innes H, Kennedy N, Mills PR, Stanley AJ, Hutchinson SJ.

Drug Alcohol Depend. 2015 Sep 1;154:125-31. doi: 10.1016/j.drugalcdep.2015.06.032. Epub 2015 Jul 2.

PMID:
26183402
15.

Fulminant hepatic failure in autoimmune polyendocrine syndrome type-1.

Sinha R, Chapman AR, Reid GT, Hayes PC.

J R Coll Physicians Edinb. 2015;45(2):136-40. doi: 10.4997/JRCPE.2015.210.

PMID:
26181530
16.

(1)H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy.

Dabos KJ, Parkinson JA, Sadler IH, Plevris JN, Hayes PC.

World J Hepatol. 2015 Jun 28;7(12):1701-7. doi: 10.4254/wjh.v7.i12.1701.

17.

U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients.

Tripathi D, Stanley AJ, Hayes PC, Patch D, Millson C, Mehrzad H, Austin A, Ferguson JW, Olliff SP, Hudson M, Christie JM; Clinical Services and Standards Committee of the British Society of Gastroenterology.

Gut. 2015 Nov;64(11):1680-704. doi: 10.1136/gutjnl-2015-309262. Epub 2015 Apr 17.

18.

Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes.

Innes HA, McDonald SA, Dillon JF, Allen S, Hayes PC, Goldberg D, Mills PR, Barclay ST, Wilks D, Valerio H, Fox R, Bhattacharyya D, Kennedy N, Morris J, Fraser A, Stanley AJ, Bramley P, Hutchinson SJ.

Hepatology. 2015 Aug;62(2):355-64. doi: 10.1002/hep.27766. Epub 2015 Mar 25.

PMID:
25716707
19.

Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland.

McAllister G, Innes H, Mcleod A, Dillon JF, Hayes PC, Fox R, Barclay ST, Templeton K, Aitken C, Gunson R, Goldberg D, Hutchinson SJ.

J Clin Virol. 2014 Nov;61(3):359-64. doi: 10.1016/j.jcv.2014.09.004. Epub 2014 Sep 16.

PMID:
25264306
20.

What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?

McDonald SA, Innes HA, Hayes PC, Dillon JF, Mills PR, Goldberg DJ, Barclay S, Allen S, Fox R, Fraser A, Kennedy N, Bhattacharyya D, Hutchinson SJ.

J Hepatol. 2015 Feb;62(2):262-8. doi: 10.1016/j.jhep.2014.08.046. Epub 2014 Sep 6.

PMID:
25195556
Items per page

Supplemental Content

Loading ...
Write to the Help Desk